Neurobiology of Alcohol Dependence -

Neurobiology of Alcohol Dependence (eBook)

eBook Download: PDF | EPUB
2014 | 1. Auflage
566 Seiten
Elsevier Science (Verlag)
978-0-12-407155-1 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
113,00 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Recent scientific advances have provided substantial information on the brain circuits and pathways relevant to various aspects of dependence. Neurobiology of Alcohol Dependence highlights the most recent data at the molecular, cellular, neurocircuitry, and behavioral levels, fostering an understanding how neuroplasticity and neuroadaptation occur, and how different neural pathways and neurocircuits contribute to dependence.
  • Highlights recent advances in understanding alcohol addiction from molecular, cellular, neurocircuitry, and behavioral levels
  • Integrates several emerging areas of research and discusses the application of novel research techniques to the understanding of alcohol dependence
  • Chapters authored by leaders in the field around the globe - the broadest, most expert coverage available

Recent scientific advances have provided substantial information on the brain circuits and pathways relevant to various aspects of dependence. Neurobiology of Alcohol Dependence highlights the most recent data at the molecular, cellular, neurocircuitry, and behavioral levels, fostering an understanding how neuroplasticity and neuroadaptation occur, and how different neural pathways and neurocircuits contribute to dependence. Highlights recent advances in understanding alcohol addiction from molecular, cellular, neurocircuitry, and behavioral levels Integrates several emerging areas of research and discusses the application of novel research techniques to the understanding of alcohol dependence Chapters authored by leaders in the field around the globe - the broadest, most expert coverage available

Contributors


R. Adron Harris,     Waggoner Center for Alcohol and Addiction Research, University of Texas–Austin, USA

Somayeh Ahmadiantehrani,     The Gallo Research Center, Department of Neurology, University of California, San Francisco, USA

Nigel S. Atkinson,     Waggoner Center for Alcohol & Addiction Research, Department of Neuroscience, University of Texas–Austin, USA

Erich J. Baker,     Computer Science Department, Baylor University, USA

Sridevi Balaraman,     Texas A&M Health Science Center, College of Medicine, Department of Neuroscience and Experimental Therapeutics, USA

Jacqueline M. Barker,     Department of Neurosciences and Center for Drug and Alcohol Programs, Medical University of South Carolina, USA

Howard C. Becker,     Charleston Alcohol Research Center, Departments of Psychiatry and Neurosciences, Medical University of South Carolina, Charleston, SC USA

Elizabeth J. Burnett,     Department of Neurosciences and Center for Drug and Alcohol Programs, Medical University of South Carolina, USA

Elissa J. Chesler,     The Jackson Laboratory, USA

John C. Crabbe,     Portland Alcohol Research Center, Veterans Affairs Medical Center, Department of Behavioral Neuroscience, Oregon Health & Science University, USA

Howard J. Edenberg,     Department of Biochemistry and Molecular Biology, and Department of Medical and Molecular Genetics, Indiana University School of Medicine, USA

Betsy Ferguson,     Division of Neurosciences, Oregon National Primate Research Center, USA

C. Fernando Valenzuela,     Department of Neurosciences, School of Medicine, University of New Mexico Health Sciences Center, USA

Tatiana Foroud,     Department of Medical and Molecular Genetics, Indiana University School of Medicine, USA

Alfredo Ghezzi,     Waggoner Center for Alcohol & Addiction Research, Department of Neuroscience, University of Texas–Austin, USA

Nicholas W. Gilpin,     Department of Physiology, Louisiana State University Health Sciences Center, USA

William B. Glen,     Department of Neurosciences and Center for Drug and Alcohol Programs, Medical University of South Carolina, USA

Kathleen A. Grant

Division of Neurosciences, Oregon National Primate Research Center, USA

Department of Behavioral Neurosciences, Oregon Health and Science University, USA

Christa Helms,     Division of Neurosciences, Oregon National Primate Research Center, USA

Linzy M. Hendrickson,     Waggoner Center for Alcohol and Addiction Research, University of Texas, Austin, USA

Andrew Holmes,     Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, USA

Patricia H. Janak,     The Gallo Research Center, Department of Neurology, University of California, San Francisco, USA

L. Judson Chandler,     Department of Neurosciences and Center for Drug and Alcohol Programs, Medical University of South Carolina, USA

Thomas L. Kash,     The Bowles Center for Alcohol Studies and the Department of Pharmacology, The University of North Carolina at Chapel Hill, USA

George F. Koob,     Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, USA

Remi Legastelois,     The Gallo Research Center, Department of Neurology, University of California, San Francisco, USA

Virginia Long,     The Gallo Research Center, Department of Neurology, University of California, San Francisco, USA

David M. Lovinger,     Section on Synaptic Pharmacology, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, USA

Emily G. Lowery-Gionta,     The Bowles Center for Alcohol Studies and the Department of Pharmacology, The University of North Carolina at Chapel Hill, USA

Ketan Marballi,     Waggoner Center for Alcohol and Addiction Research, University of Texas–Austin, USA

R. Dayne Mayfield,     Waggoner Center for Alcohol and Addiction Research, University of Texas–Austin, USA

Mary E. McCaul

Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, USA

Department of Medicine, The Johns Hopkins University School of Medicine, USA

Megan McClintick,     Department of Behavioral Neurosciences, Oregon Health and Science University, USA

Rajesh C. Miranda,     Texas A&M Health Science Center, College of Medicine, Department of Neuroscience and Experimental Therapeutics, USA

Hitoshi Morikawa,     Waggoner Center for Alcohol and Addiction Research, University of Texas, Austin, USA

Russell A. Morton,     Department of Neurosciences, School of Medicine, University of New Mexico Health Sciences Center, USA

Subhash C. Pandey,     Department of Psychiatry, University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, Illinois, USA

Matthew J. Pava,     Section on Synaptic Pharmacology, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, USA

Adolf Pfefferbaum

Neuroscience Program, SRI International, USA

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, USA

Charles L. Pickens,     Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, USA

Igor Ponomarev,     Waggoner Center for Alcohol and Addiction Research, University of Texas–Austin, USA

Anna K. Radke,     Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, USA

Marisa Roberto,     Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, USA

Dorit Ron,     The Gallo Research Center, Department of Neurology, University of California, San Francisco, USA

Adrian Rothenfluh,     Department of Psychiatry, Program in Neuroscience, UT Southwestern Medical Center, USA

Garrett E. Seale,     Institute of Neurobiology, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA

Dongju Seo,     Department of Psychiatry, Yale University School of Medicine, USA

Rajita Sinha,     Department of Psychiatry, Yale University School of Medicine, USA

Mary Ann C. Stephens,     Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, USA

Garret D. Stuber

Departments of Psychiatry & Cell and Molecular Physiology, Bowles Center for Alcohol Studies, University of North Carolina, USA

Department of Cell Biology and Physiology, Neuroscience Center, Bowles Center for Alcohol Studies, University of North Carolina, USA

Edith V. Sullivan,     Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, USA

Karen Szumlinski,     Department of Psychological and Brain Sciences, University of California–Santa Barbara, USA

Steven N. Treistman,     Institute of Neurobiology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA

Benjamin R. Troutwine,     Waggoner...

Erscheint lt. Verlag 2.5.2014
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Suchtkrankheiten
ISBN-10 0-12-407155-4 / 0124071554
ISBN-13 978-0-12-407155-1 / 9780124071551
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 42,4 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 7,9 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich